Search results for "Typical carcinoid"

showing 3 items of 3 documents

Lung nodule 25 years after lobectomy - recurrence of bronchial carcinoid

2020

OBJECTIVE Introduction: Bronchopulmonary (BP) carcinoids are low and intermediate grade tumors, seen in adults between fourth to sixth decade, where no clear association with tobacco smoking is established. Most often they are sporadic lesions (95%). Half of patients have no symptoms and the tumor is incidentally found on a chest x- ray. BP carcinoids have a good prognostic, however there is a risk of distant metastasis and the recurrences are frequent. Therefore a crucial role of vigilant follow- up, extending far beyond 5 years. PATIENTS AND METHODS Case presentation: We report a case of 73 years old women, with history of recurrent pulmonary infections, and positive family history for lu…

Adultmedicine.medical_specialtyLung NeoplasmsCarcinoid TumorNeuroendocrine tumorsmedicineHumansFamily historyIntermediate GradeLung cancerLungPathologicalAgedLungbusiness.industryNodule (medicine)General Medicinemedicine.diseasemedicine.anatomical_structuretypical carcinoidFemaleTypical carcinoidBronchopulmonary carcinoidRadiologyNeoplasm Recurrence Localmedicine.symptomneuroendocrine tumorsTomography X-Ray ComputedbusinessWiadomości Lekarskie
researchProduct

Neuroendocrine Neoplasms (NENs)

2021

Neuroendocrine neoplasms (NENs) represent a rare and heterogeneous group of malignancies which can develop in many different sites of our body. They originate from the cells of the diffuse neuroendocrine system. Gastroenteropancreatic NENs were classified in four categories, including NETs G1 (WD with 20% Ki-67), and NECs (PD with >20% Ki-67) in accordance with the 2019 WHO classification (IARC WHO Classification of the digestive system tumors, on 11th July 2019). Lung NENs, in accordance with the latest WHO classification, 2015 edition, are distinguished in small cell lung cancer (SCLC), large cell neuroendocrine carcinoma (LCNEC), atypical carcinoid (AC), and typical carcinoid (TC).

Pathologymedicine.medical_specialtyHeterogeneous groupLungmedicine.anatomical_structurebusiness.industryMedicineTypical carcinoidNon small cellLarge-cell neuroendocrine carcinomaWho classificationbusinessAtypical carcinoid
researchProduct

<p>Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Sys…

2020

Abstract Neuroendocrine tumors (NETs) of the lung are well-differentiated neuroendocrine neoplasms (NENs) with a heterogeneous clinical behaviour. Unlike gastroenteropancreatic NENs where therapeutic armamentarium clearly increased over the last decade, everolimus represented the only clinical practical innovation for lung NET patients over the last years. Therefore, for lung NETs, a multidisciplinary discussion within a dedicated team remains critical for an adequate decision-making. Although the main regulatory authorities considered the everolimus-related evidence is enough to approve the drug in advanced lung NETs, several clinical features deserve to be discussed. In this review, we sy…

medicine.medical_specialtytargeted agentsEverolimusLungbusiness.industryContext (language use)Reviewrespiratory systemNeuroendocrine tumorseverolimusmedicine.diseaseatypical carcinoidClinical Practicelung NETtypical carcinoidmedicine.anatomical_structureOncologymammalian target of rapamycin (mTOR) inhibitormedicineTypical carcinoidIntensive care medicinebusinessAtypical carcinoidClinical evaluationmedicine.drugLung Cancer: Targets and Therapy
researchProduct